Lindholt Jes S, Juul Svend, Fasting Helge, Henneberg Eskild W
Vascular Research Unit, Department of Vascular Surgery, Sygehus Viborg, DK-8800 Viborg, Denmark.
BMJ. 2005 Apr 2;330(7494):750. doi: 10.1136/bmj.38369.620162.82. Epub 2005 Mar 9.
To determine whether screening Danish men aged 65 or more for abdominal aortic aneurysms reduces mortality.
Single centre randomised controlled trial.
All five hospitals in Viborg County, Denmark.
All 12,639 men born during 1921-33 and living in Viborg County. In 1994 we included men born 1921-9 (64-73 years). We also included men who became 65 during 1995-8.
Men were randomised to the intervention group (screening by abdominal ultrasonography) or control group. Participants with an abdominal aortic aneurysm > 5 cm were referred for surgical evaluation, and those with smaller aneurysms were offered annual scans.
Specific mortality due to abdominal aortic aneurysm, overall mortality, and number of planned and emergency operations for abdominal aortic aneurysms.
4860 of 6333 men were screened (attendance rate 76.6%). 191 (4.0% of those screened) had abdominal aortic aneurysms. The mean follow-up time was 52 months. The screened group underwent 75% (95% confidence interval 51% to 91%) fewer emergency operations than the control group. Deaths due to abdominal aortic aneurysms occurred in nine patients in the screened group and 27 in the control group. The number needed to screen to save one life was 352. Specific mortality was significantly reduced by 67% (29% to 84%). Mortality due to non-abdominal aortic aneurysms was non-significantly reduced by 8%. The benefits of screening may increase with time.
Mass screening for abdominal aortic aneurysms in Danish men aged 65 or more reduces mortality.
确定对65岁及以上丹麦男性进行腹主动脉瘤筛查是否能降低死亡率。
单中心随机对照试验。
丹麦维堡县的所有五家医院。
所有出生于1921年至1933年且居住在维堡县的12639名男性。1994年,我们纳入了出生于1921年至1929年(64至73岁)的男性。我们还纳入了在1995年至1998年期间年满65岁的男性。
男性被随机分为干预组(通过腹部超声检查进行筛查)或对照组。腹主动脉瘤直径>5 cm的参与者被转诊进行手术评估,动脉瘤较小的参与者每年接受扫描。
腹主动脉瘤导致的特异性死亡率、总死亡率以及腹主动脉瘤的计划性和急诊手术数量。
6333名男性中有4860人接受了筛查(参与率76.6%)。191人(占筛查者的4.0%)患有腹主动脉瘤。平均随访时间为52个月。筛查组的急诊手术比对照组少75%(95%置信区间51%至91%)。筛查组有9例患者死于腹主动脉瘤,对照组有27例。挽救1条生命所需的筛查人数为352人。特异性死亡率显著降低了67%(29%至84%)。非腹主动脉瘤导致的死亡率非显著降低了8%。筛查的益处可能会随着时间增加。
对65岁及以上丹麦男性进行腹主动脉瘤大规模筛查可降低死亡率。